시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 진단용 심전계 시장 보고서(2025년)
Diagnostic Electrocardiograph Global Market Report 2025
상품코드 : 1825702
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,532,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,442,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,352,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

진단용 심전계 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에는 연평균 복합 성장률(CAGR) 6.8%로 성장할 전망이며, 113억 1,000만 달러로 성장이 예측됩니다. 예측 기간의 성장은 신흥 시장에서의 헬스케어 인프라 확대, 규제 당국의 대처, 소비자의 의식 증가 및 적극적인 헬스케어, 헬스케어에 대한 투자 증가, 노인 인구 증가 등에 기인하고 있습니다. 예측 기간 주요 동향으로는 인공지능(AI)의 통합, 휴대형 및 무선 ECG 기기, 원격의료의 채용, 웨어러블 ECG 기술의 진보, 맞춤형 의료 등이 있습니다.

향후 5년간의 성장률 6.8%라고 하는 예측은 전회 예측으로부터 0.2%라고 하는 미감소를 반영하고 있습니다. 이 감소는 주로 미국과 타국가 간 관세의 영향 때문입니다. 무역 마찰은 독일과 네덜란드에서 개발된 고정밀 심전도 장치 및 웨어러블 모니터의 가격을 올려 부정맥 진단 지연과 순환기과의 경비 증가를 초래하여 미국의 심장 의료에 지장을 초래할 수 있습니다. 또한 상호관세와 무역 긴장 증가 및 제한 증가로 인한 세계 경제와 무역에 대한 악영향으로 그 영향이 더욱 광범위해질 것으로 보입니다.

심장 질환의 세계 유병률 상승은 진단용 심전계 시장의 성장을 뒷받침할 것으로 예측됩니다. 심장 질환에는 부정맥, 심장 발작, 선천성 결함, 심부전 등 심혈관계에 영향을 미치는 다양한 질병이 포함됩니다. 이러한 질병 증가는 인구의 고령화, 앉기 쉬운 라이프 스타일, 식생활의 혼란 등의 요인으로 인한 것으로, 심장 질환의 중대한 위험 인자인 비만과 고혈압의 비율이 높아지고 있습니다. 진단용 심전도(ECG)는 심장의 전기적 활동을 비침습적으로 평가함으로써 심장 질환의 조기 발견, 모니터링 및 관리에 필수적입니다. 예를 들어, 2024년 1월 미국 비영리 단체인 미국 심장협회(American Heart Association)는 심혈관 질환으로 인한 사망자 수가 93만 1,578명으로 전년 92만 8,741명에서 3,000명 미세 증가한 것으로 보고했습니다. 따라서 세계적인 심장 질환의 유병률 증가는 진단용 심전계 시장의 확대를 촉진합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향 및 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁 및 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석 및 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별 및 국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도 및 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹 및 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문 및 전략

제36장 부록

AJY
영문 목차

영문목차

A diagnostic electrocardiograph (ECG or EKG) is a medical device designed to record the electrical activity of the heart over a period of time. This device captures the electrical impulses produced by cardiac muscle depolarization, which are then converted into a visual representation (electrocardiogram) displayed either on paper or digitally on a screen. Diagnostic ECGs are crucial tools in cardiology for evaluating heart health, diagnosing various heart conditions such as arrhythmias, ischemia, and myocardial infarction (heart attacks), and monitoring the effectiveness of treatments.

The primary product and service types in diagnostic electrocardiography include resting electrocardiogram (ECG), stress electrocardiogram (ECG) devices, Holter monitors, implantable loop recorders, event monitors, mobile cardiac telemetry (MCT) devices, and smart electrocardiogram (ECG) monitors. Resting ECG devices record the heart's electrical activity while the patient is at rest, helping to detect abnormalities in heart rhythms, heart attacks, and other cardiac conditions. The lead types include 12 leads, 5 leads, and 3 leads, among others. These devices are used in hospitals, clinics, cardiac centers, ambulatory surgical centers, and other healthcare settings.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The diagnostic electrocardiograph market research report is one of a series of new reports from the business research company that provides diagnostic electrocardiograph market statistics, including diagnostic electrocardiograph industry global market size, regional shares, competitors with an diagnostic electrocardiograph market share, detailed diagnostic electrocardiograph market segments, market trends and opportunities, and any further data you may need to thrive in the diagnostic electrocardiograph industry. This diagnostic electrocardiograph market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The diagnostic electrocardiograph market size has grown strongly in recent years. It will grow from $8.12 billion in 2024 to $8.69 billion in 2025 at a compound annual growth rate (CAGR) of 7.0%. The growth in the historic period can be attributed to the aging global population, increased incidence of cardiovascular diseases, rising healthcare expenditure globally, increasing awareness and screening programs for cardiovascular health, and regulatory support for early diagnosis and treatment of cardiac conditions.

The diagnostic electrocardiograph market size is expected to see strong growth in the next few years. It will grow to $11.31 billion in 2029 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to the expansion of healthcare infrastructure in emerging markets, regulatory initiatives, rising awareness and proactive health management among consumers, increasing investments in healthcare, and a and a rising geriatric population. Major trends in the forecast period include the integration of artificial intelligence (AI), portable and wireless ECG devices, the adoption of telehealth, advancements in wearable ECG technology, and personalized medicine.

The forecast of 6.8% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. cardiac care by inflating prices of high-precision ECG machines and wearable monitors developed in Germany and the Netherlands, resulting in delayed arrhythmia diagnoses and higher cardiology department expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising global prevalence of heart disorders is anticipated to boost the growth of the diagnostic electrocardiograph market. Heart disorders encompass a variety of conditions affecting the cardiovascular system, such as arrhythmias, heart attacks, congenital defects, and heart failure. The increase in these disorders is due to factors such as aging populations, sedentary lifestyles, and poor dietary habits, which lead to higher rates of obesity and hypertension-significant risk factors for heart conditions. Diagnostic electrocardiography (ECG) is essential for the early detection, monitoring, and management of cardiac conditions by providing non-invasive assessments of the heart's electrical activity. For instance, in January 2024, the American Heart Association, a US-based nonprofit organization, reported a slight increase in cardiovascular deaths to 931,578, a rise of 3,000 from the previous year's figure of 928,741. Thus, the growing prevalence of heart disorders worldwide will drive the expansion of the diagnostic electrocardiograph market.

Leading companies in the diagnostic electrocardiograph market are focusing on advanced technologies, such as AI-powered ECG systems, to enhance the accuracy and efficiency of diagnosing cardiac conditions. Integrating AI into ECG devices improves diagnostic precision and efficiency in cardiovascular healthcare settings. For example, in June 2024, AliveCor, a US-based medical technology company, launched its KAI 12L AI technology along with the Kardia 12L ECG System. This innovation is the world's first AI capable of detecting critical cardiac conditions, including heart attacks, with a simplified lead set. The new ECG system, using patented technology, is the world's first handheld 12-lead ECG system powered by AI, featuring a unique single-cable design.

In July 2023, Inuvi Health Ltd., a UK-based provider of domiciliary health assessments and nationwide phlebotomy services, acquired Express Diagnostics for an undisclosed amount. This acquisition enhances Inuvi's diagnostics business by expanding its capabilities and enabling it to offer a broader range of diagnostic services, thereby reaching a wider client base. Express Diagnostics, based in the UK, specializes in developing and manufacturing diagnostic testing solutions, including electrocardiographs.

Major companies operating in the diagnostic electrocardiograph market are Koninklijke Philips N.V., GE Healthcare Inc., Suzuken Company Limited, Mindray Medical International Limited, Nihon Kohden Corporation, OSI Systems Inc., Fukuda Denshi Co. Ltd., Midmark Corporation, BTL Group of Companies, BioTelemetry Inc., Spacelabs Healthcare Inc., Welch Allyn Inc., Schiller AG, CardioNet Inc., VectraCor Inc., BPL Limited, SunTech Medical Inc., Mortara Instrument Inc., Allengers Medical Systems Limited, Bionet Co. Ltd., ScottCare Corporation, Nasiff Associates Inc., Compumed Inc., Norav Medical, Nexus Lifecare Pvt. Ltd.

North America was the largest region in the diagnostic electrocardiograph market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the diagnostic electrocardiograph market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the diagnostic electrocardiograph market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The diagnostic electrocardiograph market consists of revenues earned by entities providing services such as installation, maintenance, calibration, training, and consulting. The market value includes the value of related goods sold by the service provider or included within the service offering. The diagnostic electrocardiograph market also includes sales of ECG electrodes, software for ECG analysis, telemetry systems, ambulatory ECG systems, ECG cables, and leads. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Diagnostic Electrocardiograph Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on diagnostic electrocardiograph market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for diagnostic electrocardiograph ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The diagnostic electrocardiograph market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Diagnostic Electrocardiograph Market Characteristics

3. Diagnostic Electrocardiograph Market Trends And Strategies

4. Diagnostic Electrocardiograph Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Diagnostic Electrocardiograph Growth Analysis And Strategic Analysis Framework

6. Diagnostic Electrocardiograph Market Segmentation

7. Diagnostic Electrocardiograph Market Regional And Country Analysis

8. Asia-Pacific Diagnostic Electrocardiograph Market

9. China Diagnostic Electrocardiograph Market

10. India Diagnostic Electrocardiograph Market

11. Japan Diagnostic Electrocardiograph Market

12. Australia Diagnostic Electrocardiograph Market

13. Indonesia Diagnostic Electrocardiograph Market

14. South Korea Diagnostic Electrocardiograph Market

15. Western Europe Diagnostic Electrocardiograph Market

16. UK Diagnostic Electrocardiograph Market

17. Germany Diagnostic Electrocardiograph Market

18. France Diagnostic Electrocardiograph Market

19. Italy Diagnostic Electrocardiograph Market

20. Spain Diagnostic Electrocardiograph Market

21. Eastern Europe Diagnostic Electrocardiograph Market

22. Russia Diagnostic Electrocardiograph Market

23. North America Diagnostic Electrocardiograph Market

24. USA Diagnostic Electrocardiograph Market

25. Canada Diagnostic Electrocardiograph Market

26. South America Diagnostic Electrocardiograph Market

27. Brazil Diagnostic Electrocardiograph Market

28. Middle East Diagnostic Electrocardiograph Market

29. Africa Diagnostic Electrocardiograph Market

30. Diagnostic Electrocardiograph Market Competitive Landscape And Company Profiles

31. Diagnostic Electrocardiograph Market Other Major And Innovative Companies

32. Global Diagnostic Electrocardiograph Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Diagnostic Electrocardiograph Market

34. Recent Developments In The Diagnostic Electrocardiograph Market

35. Diagnostic Electrocardiograph Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기